Indication
Immunoglobulin A nephropathy
Immunoglobulin A nephropathy is a chronic autoimmune renal disease and the most common primary glomerulonephritis worldwide. Read more about Immunoglobulin A nephropathy
9 drugs 7 manufacturers
Drugs that treat it
Common Immunoglobulin A nephropathy therapies.
FILSPARI (sparsentan)
FABHALTA (iptacopan HCl)
VANRAFIA (atrasentan hydrochloride)
VOYXACT (sibeprenlimab-szsi)
FABHALTA (iptacopan HCl)
VANRAFIA (atrasentan hydrochloride)
TRUTAKNA (atacicept-vymj)
TARPEYO (budesonide)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonImmunoglobulin A nephropathy is a chronic autoimmune renal disease and the most common primary glomerulonephritis worldwide.
It is pathologically characterized by the deposition of galactose-deficient immunoglobulin A1–containing immune complexes in the glomerular mesangium, triggering mesangial proliferation, local inflammation, and progressive glomerular injury.
Clinically, affected individuals typically present with microscopic or episodic gross hematuria—often concurrent with upper respiratory tract infections—along with varying degrees of proteinuria and hypertension.
The condition can affect patients of all ages, most frequently young adults, and may insidiously progress over years to chronic kidney disease and end-stage renal disease.
- medlineplus.gov
Immunoglobulin A nephropathy is a chronic autoimmune renal disease and the most common primary glomerulonephritis worldwide It is pathologically characterized by the deposition of galactose-deficient immunoglobulin A1–containing immune complexes in the glomerular mesangium, triggering mesangial proliferation, local inflammation, and progressive glomerular injury
- nih.gov
Immunoglobulin A nephropathy is a chronic autoimmune renal disease and the most common primary glomerulonephritis worldwide Clinically, affected individuals typically present with microscopic or episodic gross hematuria—often concurrent with upper respiratory tract infections—along with varying degrees of proteinuria and hypertension
- medlineplus.gov
It is pathologically characterized by the deposition of galactose-deficient immunoglobulin A1–containing immune complexes in the glomerular mesangium, triggering mesangial proliferation, local inflammation, and progressive glomerular injury
- nih.gov
It is pathologically characterized by the deposition of galactose-deficient immunoglobulin A1–containing immune complexes in the glomerular mesangium, triggering mesangial proliferation, local inflammation, and progressive glomerular injury The condition can affect patients of all ages, most frequently young adults, and may insidiously progress over years to chronic kidney disease and end-stage renal disease
- nih.gov
Clinically, affected individuals typically present with microscopic or episodic gross hematuria—often concurrent with upper respiratory tract infections—along with varying degrees of proteinuria and hypertension The condition can affect patients of all ages, most frequently young adults, and may insidiously progress over years to chronic kidney disease and end-stage renal disease
- medlineplus.gov
Clinically, affected individuals typically present with microscopic or episodic gross hematuria—often concurrent with upper respiratory tract infections—along with varying degrees of proteinuria and hypertension
Personalize your experience
Follow Immunoglobulin A nephropathy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.